253 related articles for article (PubMed ID: 34643931)
1. Review of the genomic landscape of common pediatric CNS tumors and how data sharing will continue to shape this landscape in the future.
Kaneva K; Goldman S
Mol Biol Rep; 2021 Nov; 48(11):7537-7544. PubMed ID: 34643931
[TBL] [Abstract][Full Text] [Related]
2. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
Cacciotti C; Fleming A; Ramaswamy V
J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
[TBL] [Abstract][Full Text] [Related]
3. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
Plant-Fox AS; O'Halloran K; Goldman S
Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms and therapeutic targets in pediatric brain tumors.
Liu KW; Pajtler KW; Worst BC; Pfister SM; Wechsler-Reya RJ
Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292958
[TBL] [Abstract][Full Text] [Related]
5. Advances in the biology and treatment of pediatric central nervous system tumors.
Vitanza NA; Cho YJ
Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
[TBL] [Abstract][Full Text] [Related]
6. Neuro-oncology: Genetic variation in pediatric and adult brain tumors.
Brandes AA; Franceschi E
Nat Rev Neurol; 2010 Dec; 6(12):653-4. PubMed ID: 21131914
[TBL] [Abstract][Full Text] [Related]
7. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
Robinson GW; Witt H; Resnick A
Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
[TBL] [Abstract][Full Text] [Related]
8. Adolescents and Young Adults With Cancer: CNS Tumors.
Wu J; Heidelberg RE; Gajjar A
J Clin Oncol; 2024 Feb; 42(6):686-695. PubMed ID: 38064656
[TBL] [Abstract][Full Text] [Related]
9. Mapping pediatric brain tumors to their origins in the developing cerebellum.
Okonechnikov K; Joshi P; Sepp M; Leiss K; Sarropoulos I; Murat F; Sill M; Beck P; Chan KC; Korshunov A; Sah F; Deng MY; Sturm D; DeSisto J; Donson AM; Foreman NK; Green AL; Robinson G; Orr BA; Gao Q; Darrow E; Hadley JL; Northcott PA; Gojo J; Kawauchi D; Hovestadt V; Filbin MG; von Deimling A; Zuckermann M; Pajtler KW; Kool M; Jones DTW; Jäger N; Kutscher LM; Kaessmann H; Pfister SM
Neuro Oncol; 2023 Oct; 25(10):1895-1909. PubMed ID: 37534924
[TBL] [Abstract][Full Text] [Related]
10. [Classification and Diagnostics of Pediatric Brain Tumors].
Kanemura Y
No Shinkei Geka; 2023 Sep; 51(5):778-788. PubMed ID: 37743329
[TBL] [Abstract][Full Text] [Related]
11. The unique immune ecosystems in pediatric brain tumors: integrating single-cell and bulk RNA-sequencing.
Cao L; Xie W; Ma W; Zhao H; Wang J; Liang Z; Tian S; Wang B; Ma J
Front Immunol; 2023; 14():1238684. PubMed ID: 38094301
[TBL] [Abstract][Full Text] [Related]
12. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.
Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC
J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436
[TBL] [Abstract][Full Text] [Related]
13. Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.
Leary SES; Onar-Thomas A; Fangusaro J; Gottardo NG; Cohen K; Smith A; Huang A; Haas-Kogan D; Fouladi M;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30600. PubMed ID: 37534382
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Cerebellar Tumors: Emerging Imaging Techniques and Advances in Understanding of Genetic Features.
Choudhri AF; Siddiqui A; Klimo P
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):811-821. PubMed ID: 27742118
[TBL] [Abstract][Full Text] [Related]
15. Advances on Epigenetic Drugs for Pediatric Brain Tumors.
Skouras P; Markouli M; Strepkos D; Piperi C
Curr Neuropharmacol; 2023; 21(7):1519-1535. PubMed ID: 36154607
[TBL] [Abstract][Full Text] [Related]
16. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA
Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743
[TBL] [Abstract][Full Text] [Related]
17. Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas.
Lhermitte B; Blandin AF; Coca A; Guerin E; Durand A; Entz-Werlé N
Neurochirurgie; 2021 Feb; 67(1):39-45. PubMed ID: 29776650
[TBL] [Abstract][Full Text] [Related]
18. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
Kool M; Koster J; Bunt J; Hasselt NE; Lakeman A; van Sluis P; Troost D; Meeteren NS; Caron HN; Cloos J; Mrsić A; Ylstra B; Grajkowska W; Hartmann W; Pietsch T; Ellison D; Clifford SC; Versteeg R
PLoS One; 2008 Aug; 3(8):e3088. PubMed ID: 18769486
[TBL] [Abstract][Full Text] [Related]
19. Developmental origins and oncogenic pathways in malignant brain tumors.
Lu QR; Qian L; Zhou X
Wiley Interdiscip Rev Dev Biol; 2019 Jul; 8(4):e342. PubMed ID: 30945456
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
Nobusawa S; Hirato J; Yokoo H
Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]